Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Solnatide

Generic Name: Solnatide

Drug Type: Biotech

CAS Number: 259206-53-6

Unique Ingredient Identifier: 17ZS80333G

Overview

Solnatide has been used in trials studying the treatment of Acute Lung Injury.

Background

Solnatide has been used in trials studying the treatment of Acute Lung Injury.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

Phase 3

Not yet recruiting

Posted: 2025/04/18

Sponsor:

Alebund Pharmaceutic...

ID:NCT06933472

A Pharmacodynamic Effect Study of AP301 in Healthy Volunteers

Phase 1

Completed

Posted: 2023/10/25

Sponsor:Alebund Pty Ltd

ID:NCT06100627

Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS

Phase 2

Completed

Posted: 2018/06/26

Sponsor:Apeptico Forschung u...

ID:NCT03567577

Study in Intensive Care Patients Regarding the Effect of Inhaled AP-301 After Primary Graft Dysfunction After Lung Transplantation

Phase 2

Completed

Posted: 2014/03/26

Sponsor:Apeptico Forschung u...

ID:NCT02095626

Study in Intensive Care Patients to Investigate the Clinical Effect of Repetitive Orally Inhaled Doses of AP301 on Alveolar Liquid Clearance in Acute Lung Injury

Phase 2

Completed

Posted: 2012/06/26

Sponsor:Apeptico Forschung u...

ID:NCT01627613

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy